comparemela.com

Page 4 - நோயெதிர்ப்பு மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Enthusiasm for Once-Monthly Cabenuva Is High—But There Are Questions, Too

Enthusiasm for Once-Monthly Cabenuva Is High But There Are Questions, Too The landmark U.S. Food and Drug Administration (FDA) approval of the first long-acting injectable HIV regimen, Cabenuva (cabotegravir/rilpivirine), in January burst open a new treatment door for many people living with HIV (PLWH). The approval signaled a move from daily pills to two shots in the butt one for cabotegravir and the other for rilpivirine once a month. You may be asking, though, will doctors now start switching PLWH en masse from pills to injections? The short answer is no. And not everyone will even want to make the switch, although clinicians who recently spoke with TheBody said that, at least for the people who’ve heard about Cabenuva, enthusiasm is high.

One-year vaccine interval fine but 4 weeks ideal: Virologist | Bengaluru News

Green up is getting close

Green up is getting close Tracy Sinclare © Provided by Anchorage KTUU-TV Trees are getting ready to sprout leaves. ANCHORAGE, Alaska (KTUU) - Anchorage is on the verge of “green up,” that period of time when the trees and grass shift from brown to green. Rick Thoman, climate specialist with the Alaska Center for Climate Assessment and Policy, has forecasted green up for some time between May 6 and 10. Fairbanks is just a day or two behind that. Green up was defined by forest ecologists at the University of Alaska-Fairbanks many years ago, looking at the greening of the boreal forest. One thing Thoman was very specific about is that green up is a large-scale phenomenon.

Why Hay Fever Has Got Worse In The Last 5 Years

Constantinis via Getty Images Almost half of the UK population struggle with hay fever symptoms, according to a survey by Allergy UK – nearly double the number previously thought. The issue, also known as seasonal allergic rhinitis, occurs when your body has an allergic reaction to pollen – typically when it comes into contact with your mouth, nose, eyes and throat. It was previously estimated to affect somewhere between 10 and 13 million people in the UK, or 20-30% of the population. But a survey of 7,000 people by Allergy UK and Kleenex reveals that far more people may be struggling. There’s also been a “significant increase” in the number of those with the allergy – more than a third (37%) said they had developed symptoms for the first time in the last five years.

Stateside: vaccine incentives, increasing minority access to nature; allergy season soaring

Today s Environment Report examines the link between allergies and climate change If even hearing the word “ragweed” makes your eyes water, you might be one of the nearly 45 million Americans with seasonal allergies. Researchers say climate change is fueling the rise in allergies and asthma. Jenny Fischer has been taking over-the-counter medication for allergies for a long time. Without it, she suffers cold-like symptoms: a runny nose, sneezing and congestion. An allergy pill usually made it better. But a couple of years ago, things started to get worse. “I’d be out at 5:30 in the morning walking my dog, and it would just be huffing and puffing. And, you know, I couldn’t catch my breath. It s scary, she said.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.